Works matching IS 14628902 AND DT 2025 AND VI 27 AND IP 4
Results: 68
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. C1, doi. 10.1111/dom.16322
- By:
- Publication type:
- Article
Association of metabolic dysfunction‐associated fatty liver disease with white matter hyperintensity and cognitive decline: A longitudinal cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2271, doi. 10.1111/dom.16232
- By:
- Publication type:
- Article
Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2259, doi. 10.1111/dom.16231
- By:
- Publication type:
- Article
Effectiveness of gemigliptin on risk of major adverse kidney events in people with type 2 diabetes: A Korean cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2313, doi. 10.1111/dom.16230
- By:
- Publication type:
- Article
Fibroblast growth factor 23 predicts incident diabetic kidney disease: A 4.6‐year prospective study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2232, doi. 10.1111/dom.16224
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of GLP‐1 receptor agonists on cardiovascular events and risk factors: A review and network meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1735, doi. 10.1111/dom.16228
- By:
- Publication type:
- Article
MiniMed 780G system performance in older users with type 1 diabetes: Real‐world evidence and the case for stricter glycaemic targets.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2242, doi. 10.1111/dom.16227
- By:
- Publication type:
- Article
Long‐term use of Minimed™ 780G in children and adolescents with type 1 diabetes under real‐world conditions: The benefits of optimal settings.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2309, doi. 10.1111/dom.16226
- By:
- Publication type:
- Article
The role of gut–islet axis in pancreatic islet function and glucose homeostasis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1676, doi. 10.1111/dom.16225
- By:
- Publication type:
- Article
Alternative dosing regimens of GLP‐1 receptor agonists may reduce costs and maintain weight loss efficacy.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2251, doi. 10.1111/dom.16229
- By:
- Publication type:
- Article
Oral TIX100 protects against obesity‐associated glucose intolerance and diet‐induced adiposity.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2223, doi. 10.1111/dom.16223
- By:
- Publication type:
- Article
Survey among adult users of semaglutide for weight loss in Denmark: User characteristics, treatment expectations and experienced effects.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2214, doi. 10.1111/dom.16222
- By:
- Publication type:
- Article
Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2305, doi. 10.1111/dom.16221
- By:
- Publication type:
- Article
Efficacy of high‐intensity interval training in individuals with type 2 diabetes mellitus: An umbrella review of systematic reviews and meta‐analyses.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1719, doi. 10.1111/dom.16220
- By:
- Publication type:
- Article
Actual weight loss trajectories after bariatric surgery compared with the SOPHIA prediction tool: An observational comparison study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2206, doi. 10.1111/dom.16219
- By:
- Publication type:
- Article
Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in India.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2193, doi. 10.1111/dom.16218
- By:
- Publication type:
- Article
Diabetes and incident stroke and mediation by microvascular dysfunction: Pooled analysis of three population‐based studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2299, doi. 10.1111/dom.16217
- By:
- Publication type:
- Article
The physiological impact of an N‐terminal Halo‐tag on glucose‐dependent insulinotropic polypeptide receptor function in mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2294, doi. 10.1111/dom.16216
- By:
- Publication type:
- Article
Clinical effectiveness and cost‐effectiveness of first‐line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2183, doi. 10.1111/dom.16215
- By:
- Publication type:
- Article
Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2173, doi. 10.1111/dom.16214
- By:
- Publication type:
- Article
Targeted metabolomics reveals novel biomarkers for gestational diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2163, doi. 10.1111/dom.16213
- By:
- Publication type:
- Article
Impact of time in tight range on all‐cause and cardiovascular mortality in type 2 diabetes: A prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2154, doi. 10.1111/dom.16212
- By:
- Publication type:
- Article
Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2147, doi. 10.1111/dom.16211
- By:
- Publication type:
- Article
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2138, doi. 10.1111/dom.16210
- By:
- Publication type:
- Article
Evaluation of the analytical and clinical accuracy of four blood glucose meters in pregnant women with hyperglycaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2131, doi. 10.1111/dom.16209
- By:
- Publication type:
- Article
Follistatins, activins and inhibins during osteoporosis therapy with denosumab or zoledronate and after their discontinuation.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2288, doi. 10.1111/dom.16208
- By:
- Publication type:
- Article
Comparative effectiveness of insulin glargine, glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter‐2 inhibitors in veterans with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2120, doi. 10.1111/dom.16207
- By:
- Publication type:
- Article
Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1708, doi. 10.1111/dom.16206
- By:
- Publication type:
- Article
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP‐1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose‐escalation Phase I study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2110, doi. 10.1111/dom.16203
- By:
- Publication type:
- Article
Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2096, doi. 10.1111/dom.16202
- By:
- Publication type:
- Article
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in UK primary care: A retrospective, real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2086, doi. 10.1111/dom.16201
- By:
- Publication type:
- Article
Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2284, doi. 10.1111/dom.16200
- By:
- Publication type:
- Article
Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2070, doi. 10.1111/dom.16199
- By:
- Publication type:
- Article
Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub‐analysis of a randomized controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2059, doi. 10.1111/dom.16198
- By:
- Publication type:
- Article
Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2044, doi. 10.1111/dom.16197
- By:
- Publication type:
- Article
Association of changes in the type 2 diabetes and MASLD/related SLD status with risk of developing cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2035, doi. 10.1111/dom.16196
- By:
- Publication type:
- Article
Prognostic value of changes in vibration‐controlled transient elastography parameters for liver, cardiovascular and mortality outcomes in individuals with type 2 diabetes and metabolic dysfunction‐associated steatotic liver disease: The Rio de Janeiro type 2 diabetes cohort
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2024, doi. 10.1111/dom.16195
- By:
- Publication type:
- Article
Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2012, doi. 10.1111/dom.16194
- By:
- Publication type:
- Article
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 2002, doi. 10.1111/dom.16193
- By:
- Publication type:
- Article
Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1992, doi. 10.1111/dom.16192
- By:
- Publication type:
- Article
Unexpected cardiovascular risks of glucagon‐like peptide‐1 receptor agonist and aspirin co‐administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1980, doi. 10.1111/dom.16191
- By:
- Publication type:
- Article
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1972, doi. 10.1111/dom.16190
- By:
- Publication type:
- Article
Effects of antidiabetic agents on lipid metabolism of skeletal muscle: A narrative review.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1693, doi. 10.1111/dom.16189
- By:
- Publication type:
- Article
Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1960, doi. 10.1111/dom.16188
- By:
- Publication type:
- Article
Impact of a very low‐calorie ketogenic diet on metabolic and microbiota outcomes in post‐bariatric patients and bariatric‐Naïve individuals: A comparative pilot study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1950, doi. 10.1111/dom.16187
- By:
- Publication type:
- Article
Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1940, doi. 10.1111/dom.16186
- By:
- Publication type:
- Article
Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1932, doi. 10.1111/dom.16185
- By:
- Publication type:
- Article
Baseline and cumulative Chinese visceral adiposity index and diabetic kidney disease: A prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1920, doi. 10.1111/dom.16184
- By:
- Publication type:
- Article
Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population‐based study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1902, doi. 10.1111/dom.16183
- By:
- Publication type:
- Article
MicroRNA‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 4, p. 1888, doi. 10.1111/dom.16182
- By:
- Publication type:
- Article